nodes	percent_of_prediction	percent_of_DWPC	metapath
Palonosetron—Distention—Octreotide—thymus cancer	0.113	0.113	CcSEcCtD
Palonosetron—Pruritus generalised—Octreotide—thymus cancer	0.08	0.08	CcSEcCtD
Palonosetron—Sinus bradycardia—Octreotide—thymus cancer	0.0544	0.0544	CcSEcCtD
Palonosetron—Hyperbilirubinaemia—Octreotide—thymus cancer	0.0294	0.0294	CcSEcCtD
Palonosetron—Injection site reaction—Octreotide—thymus cancer	0.0265	0.0265	CcSEcCtD
Palonosetron—Hyperkalaemia—Octreotide—thymus cancer	0.0262	0.0262	CcSEcCtD
Palonosetron—Influenza like illness—Octreotide—thymus cancer	0.0259	0.0259	CcSEcCtD
Palonosetron—Hot flush—Octreotide—thymus cancer	0.0207	0.0207	CcSEcCtD
Palonosetron—Menopausal symptoms—Octreotide—thymus cancer	0.0205	0.0205	CcSEcCtD
Palonosetron—Anaphylactoid reaction—Octreotide—thymus cancer	0.02	0.02	CcSEcCtD
Palonosetron—Pain in extremity—Octreotide—thymus cancer	0.0194	0.0194	CcSEcCtD
Palonosetron—Abdominal pain upper—Octreotide—thymus cancer	0.0177	0.0177	CcSEcCtD
Palonosetron—Gastritis—Octreotide—thymus cancer	0.0172	0.0172	CcSEcCtD
Palonosetron—Abdominal distension—Octreotide—thymus cancer	0.0169	0.0169	CcSEcCtD
Palonosetron—Hyperglycaemia—Octreotide—thymus cancer	0.0151	0.0151	CcSEcCtD
Palonosetron—Hepatobiliary disease—Octreotide—thymus cancer	0.0141	0.0141	CcSEcCtD
Palonosetron—Epistaxis—Octreotide—thymus cancer	0.0141	0.0141	CcSEcCtD
Palonosetron—Sinusitis—Octreotide—thymus cancer	0.014	0.014	CcSEcCtD
Palonosetron—Bradycardia—Octreotide—thymus cancer	0.0136	0.0136	CcSEcCtD
Palonosetron—Tinnitus—Octreotide—thymus cancer	0.0125	0.0125	CcSEcCtD
Palonosetron—Cardiac disorder—Octreotide—thymus cancer	0.0124	0.0124	CcSEcCtD
Palonosetron—Immune system disorder—Octreotide—thymus cancer	0.0121	0.0121	CcSEcCtD
Palonosetron—Arrhythmia—Octreotide—thymus cancer	0.012	0.012	CcSEcCtD
Palonosetron—Alopecia—Octreotide—thymus cancer	0.0118	0.0118	CcSEcCtD
Palonosetron—Mental disorder—Octreotide—thymus cancer	0.0117	0.0117	CcSEcCtD
Palonosetron—Malnutrition—Octreotide—thymus cancer	0.0117	0.0117	CcSEcCtD
Palonosetron—Erythema—Octreotide—thymus cancer	0.0117	0.0117	CcSEcCtD
Palonosetron—Flatulence—Octreotide—thymus cancer	0.0115	0.0115	CcSEcCtD
Palonosetron—Anaemia—Octreotide—thymus cancer	0.0108	0.0108	CcSEcCtD
Palonosetron—Convulsion—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Palonosetron—Hypertension—Octreotide—thymus cancer	0.0101	0.0101	CcSEcCtD
Palonosetron—Myalgia—Octreotide—thymus cancer	0.00994	0.00994	CcSEcCtD
Palonosetron—Arthralgia—Octreotide—thymus cancer	0.00994	0.00994	CcSEcCtD
Palonosetron—Anxiety—Octreotide—thymus cancer	0.0099	0.0099	CcSEcCtD
Palonosetron—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00987	0.00987	CcSEcCtD
Palonosetron—Discomfort—Octreotide—thymus cancer	0.00982	0.00982	CcSEcCtD
Palonosetron—Dry mouth—Octreotide—thymus cancer	0.00972	0.00972	CcSEcCtD
Palonosetron—Anaphylactic shock—Octreotide—thymus cancer	0.00953	0.00953	CcSEcCtD
Palonosetron—Infection—Octreotide—thymus cancer	0.00946	0.00946	CcSEcCtD
Palonosetron—Shock—Octreotide—thymus cancer	0.00937	0.00937	CcSEcCtD
Palonosetron—Nervous system disorder—Octreotide—thymus cancer	0.00934	0.00934	CcSEcCtD
Palonosetron—Tachycardia—Octreotide—thymus cancer	0.0093	0.0093	CcSEcCtD
Palonosetron—Skin disorder—Octreotide—thymus cancer	0.00925	0.00925	CcSEcCtD
Palonosetron—Anorexia—Octreotide—thymus cancer	0.00908	0.00908	CcSEcCtD
Palonosetron—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00868	0.00868	CcSEcCtD
Palonosetron—Insomnia—Octreotide—thymus cancer	0.00862	0.00862	CcSEcCtD
Palonosetron—Paraesthesia—Octreotide—thymus cancer	0.00855	0.00855	CcSEcCtD
Palonosetron—Dyspnoea—Octreotide—thymus cancer	0.00849	0.00849	CcSEcCtD
Palonosetron—Somnolence—Octreotide—thymus cancer	0.00847	0.00847	CcSEcCtD
Palonosetron—Dyspepsia—Octreotide—thymus cancer	0.00838	0.00838	CcSEcCtD
Palonosetron—Decreased appetite—Octreotide—thymus cancer	0.00828	0.00828	CcSEcCtD
Palonosetron—Gastrointestinal disorder—Octreotide—thymus cancer	0.00822	0.00822	CcSEcCtD
Palonosetron—Fatigue—Octreotide—thymus cancer	0.00821	0.00821	CcSEcCtD
Palonosetron—Pain—Octreotide—thymus cancer	0.00815	0.00815	CcSEcCtD
Palonosetron—Constipation—Octreotide—thymus cancer	0.00815	0.00815	CcSEcCtD
Palonosetron—Gastrointestinal pain—Octreotide—thymus cancer	0.00779	0.00779	CcSEcCtD
Palonosetron—Abdominal pain—Octreotide—thymus cancer	0.00753	0.00753	CcSEcCtD
Palonosetron—Body temperature increased—Octreotide—thymus cancer	0.00753	0.00753	CcSEcCtD
Palonosetron—Hypersensitivity—Octreotide—thymus cancer	0.00702	0.00702	CcSEcCtD
Palonosetron—Asthenia—Octreotide—thymus cancer	0.00683	0.00683	CcSEcCtD
Palonosetron—Pruritus—Octreotide—thymus cancer	0.00674	0.00674	CcSEcCtD
Palonosetron—Diarrhoea—Octreotide—thymus cancer	0.00652	0.00652	CcSEcCtD
Palonosetron—Dizziness—Octreotide—thymus cancer	0.0063	0.0063	CcSEcCtD
Palonosetron—Vomiting—Octreotide—thymus cancer	0.00606	0.00606	CcSEcCtD
Palonosetron—Rash—Octreotide—thymus cancer	0.00601	0.00601	CcSEcCtD
Palonosetron—Dermatitis—Octreotide—thymus cancer	0.006	0.006	CcSEcCtD
Palonosetron—Headache—Octreotide—thymus cancer	0.00597	0.00597	CcSEcCtD
Palonosetron—Nausea—Octreotide—thymus cancer	0.00566	0.00566	CcSEcCtD
